Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Healthcare Workers before the Era of Vaccination at a Tertiary Care Hospital in Turkey
Meliha Cagla Sonmezer,
Enes Erul,
Taha Koray Sahin,
Ipek Rudvan Al,
Yasemin Cosgun,
Gulay Korukluoglu,
Humeyra Zengin,
Gülçin Telli Dizman,
Ahmet Cagkan Inkaya,
Serhat Unal
Affiliations
Meliha Cagla Sonmezer
Infectious Diseases and Clinical Microbiology Department, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey
Enes Erul
Internal Medicine Department, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey
Taha Koray Sahin
Internal Medicine Department, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey
Ipek Rudvan Al
Infectious Diseases and Clinical Microbiology Department, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey
Yasemin Cosgun
National Arboviruses and Viral Zoonotic Diseases Laboratory, Microbiology Reference Laboratories Department, Public Health General Directorate of Turkey, 06100 Ankara, Turkey
Gulay Korukluoglu
National Arboviruses and Viral Zoonotic Diseases Laboratory, Microbiology Reference Laboratories Department, Public Health General Directorate of Turkey, 06100 Ankara, Turkey
Humeyra Zengin
Infectious Diseases and Clinical Microbiology Department, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey
Gülçin Telli Dizman
Infectious Diseases and Clinical Microbiology Department, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey
Ahmet Cagkan Inkaya
Infectious Diseases and Clinical Microbiology Department, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey
Serhat Unal
Infectious Diseases and Clinical Microbiology Department, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey
Healthcare workers (HCWs), as frontliners, are assumed to be among the highest risk groups for COVID-19 infection, especially HCWs directly involved in patient care. However, the data on the COVID-19 infection and seroprevalence rates are limited in HCWs. Therefore, we aimed to evaluate the seroprevalence rates in HCWs according to risk groups for COVID-19 contraction in a large cross-sectional study from a tertiary care hospital in Turkey. We enrolled 1974 HCWs before the vaccination programs. In two separate semi-quantitative ELISAs, either IgA or IgG antibodies against SARS-CoV-2 spike protein subunit 1 (S1) were measured. The proportion of positive test results for IgG, IgA, or both against SARS-CoV-2 of study subjects was 19% (375/1974). Frontline HCWs who had contact with patients (21.7%, RR 2.1 [1.51–2.92]) and HCWs in working in the COVID-19 units, intensive care units, or emergency department (19.7%, RR 1.61 [1.12–2.32]) had a notably higher Anti-SARS-CoV-2 IgG compared to the rest of HCWs who has no daily patient contacts ([11.1%]; p < 0.0001). HCWs who care for regular patients in the medium-risk group have also experienced a sustained higher risk of exposure to SARS-CoV-2. We should enhance the precaution against COVID-19 to protect HCW’s safety through challenging times.